HER2 as a potential therapeutic target on quiescent prostate cancer cells is a research paper published in Translational Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Department of Defense Prostate Cancer Research Program
Grant: W81XWH-15-1-0637
Department of Defense Prostate Cancer Research Program
Grant: W81XWH2010394
Department of Defense Prostate Cancer Research Program
Grant: W81XW-15-1-0413
University of Michigan
Grant: 18YOUN04
Prostate Cancer Foundation
Grant: 16CHAL05
National Cancer Institute
Grant: CA163124
National Cancer Institute
Grant: U54CA143803
National Cancer Institute
Grant: CA093900
National Cancer Institute
Grant: CA143055
U.S. Department of Defense
Grant: W81XWH-11-1-0636
National Institutes of Health
Grant: 5U54CA143803-05
Education and Training
National Institutes of Health
Grant: 1U54CA163124-01
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche
National Institutes of Health
Grant: 7U01CA143055-04
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression
National Institutes of Health
Grant: 5P01CA093900-10
Administrative Core
NCI NIH HHS
Grant: U01 CA143055
NIDCR NIH HHS
Grant: K99 DE029756
NCI NIH HHS
Grant: U54 CA163124
NCI NIH HHS
Grant: P01 CA093900
Fields of Study
Keywords